Nasal NO: Normal values in children age 6 through to 17 years

European Respiratory Journal

Volumn 26, Issue 3, 2005, Pages 453-457

  Struben, V M D ^a   Wieringa, M H ^a   Mantingh, C J ^a   Bommelje C ^a   Don, M ^b   Feenstra, L ^a   de Jongste, J C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Children; Nasal nitric oxide; Normal values

Indexed keywords

NITRIC OXIDE;

ADENOIDECTOMY; ADOLESCENT; AGE; ARTICLE; BODY MASS; BREATH HOLDING; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENDER; HUMAN; MALE; NETHERLANDS; NORMAL VALUE; PASSIVE SMOKING; PRIORITY JOURNAL; RELIABILITY; RESPIRATORY TRACT DISEASE; SEX RATIO;

ADOLESCENT; AGE FACTORS; ALGORITHMS; CHEMILUMINESCENT MEASUREMENTS; CHILD; FEMALE; HUMANS; MALE; NASAL CAVITY; NITRIC OXIDE; REFERENCE VALUES;

EID: 24644523293     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00015205     Document Type: Article

References (50)

1. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181: 852-857.
2. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368-1370.
3. Lundberg JO, Rinder J, Weitzberg E, Lundberg JM, Alving K. Nasally exhaled nitric oxide in humans originates mainly in the paranasal sinuses. Acta Physiol Scand 1994; 152: 431-432.
4. Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol 1983; 46: 198-202.
5. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995; 1: 370-373.
6. Runer T, Cervin A, Lindberg S, Uddman R. Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg 1998; 119: 278-287.
7. Puybasset L, Rouby JJ, Mourgeon E, et al. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 1994; 20: 319-327.
8. Colantonio D, Brouillette L, Parikh A, Scadding GK. Paradoxical low nasal nitric oxide in nasal polyposis. Clin Exp Allergy 2002; 32: 698-701.
9. Arnal JF, Didier A, Rami J, et al. Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy 1997; 27: 358-362.
10. Arnal JF, Flores P, Rami J, et al. Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J 1999; 13: 307-312.
11. Ferguson EA, Eccles R. Changes in nasal nitric oxide concentration associated with symptoms of common cold and treatment with a topical nasal decongestant. Acta Otolaryngol 1997; 117: 614-617.
12. Wodehouse T, Kharitonov SA, Mackay IS, Barnes PJ, Wilson R, Cole PJ. Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. Eur Respir J 2003; 21: 43-47.
13. Baraldi E, Azzolin NM, Biban P, Zacchello F. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis. Am J Respir Crit Care Med 1997; 155: 1680-1683.
14. Kharitonov SA, Rajakulasingam K, O'Connor B, Durham SR, Barnes PJ. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 1997; 99: 58-64.
15. Vural C, Gungor A. The effect of topical fluticasone on nasal nitric oxide levels in a patient with allergic rhinitis. Ear Nose Throat J 2003; 82: 592-597.
16. Vural C, Gungor A. Variations of nasal nitric oxide in a subject with allergic rhinitis: a longitudinal study. Am J Otolaryngol 2002; 23: 191-195.
17. Dotsch J, Puls J, Klimek T, Rascher W. Reduction of neuronal and inducible nitric oxide synthase gene expression in patients with cystic fibrosis. Eur Arch Otorhinolaryngol 2002; 259: 222-226.
18. Dotsch J, Demirakca S, Terbrack HG, Huls G, Rascher W, Kuhl PG. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J 1996; 9: 2537-2540.
19. Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998; 102: 1200-1207.
20. Thomas SR, Kharitonov SA, Scott SF, Hodson ME, Barnes PJ. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 2000; 117: 1085-1089.
21. Grasemann H, Gartig SS, Wiesemann HG, Teschler H, Konietzko N, Ratjen F. Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome. Eur Respir J 1999; 13: 114-118.
22. Ruckes-Nilges C, Lindemann H, Klimek T, Glanz H, Weber WM. Nitric oxide has no beneficial effects on ion transport defects in cystic fibrosis human nasal epithelium. Pflugers Arch 2000; 441: 133-137.
23. Horvath I, Loukides S, Wodehouse T, et al. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 2003; 58: 68-72.
24. Noone PG, Leigh MW, Sannuti A, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004; 169: 459-467.
25. Narang I, Ersu R, Wilson NM, Bush A. Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 2002; 57: 586-589.
26. Lindberg S, Cervin A, Runer T. Low levels of nasal nitric oxide (NO) correlate to impaired mucociliary function in the upper airways. Acta Otolaryngol 1997; 117: 728-734.
27. Daya H, Qian W, McClean P, et al. Nasal nitric oxide in children: a novel measurement technique and normal values. Laryngoscope 2002; 112: 1831-1835.
28. Djupesland PG, Chatkin JM, Qian W, Haight JS. [Nitric oxide in the nose and paranasal sinuses - respiratory tract physiology in a new perspective]. Tidsskr Nor Laegeforen 1999; 119: 4070-4072.
29. Lundberg JO. Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Acta Physiol Scand Suppl 1996; 633: 1-27.
30. Henriksen AH, Sue-Chu M, Lingaas Holmen T, Langhammer A, Bjermer L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J 1999; 13:301-306.
31. Kharitonov SA, Barnes PJ. Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding. Thorax 1997; 52: 540-544.
32. Lewandowski K, Busch T, Lohbrunner H, et al. Low nitric oxide concentrations in exhaled gas and nasal airways of mammals without paranasal sinuses. J Appl Physiol 1998; 85: 405-410.
33. Lindberg S, Cervin A, Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol 1997, 117: 113-117.
34. Struben VMD, Wieringa MH, Mantingh CJ, Bommeljé CC, de Jongste JC, Feenstra L. Standardisation of nasal NO measurement. Eur Respir J 2004; 24: Suppl. 48, 270s.
35. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-491.
36. Asher MI, Weiland SK. The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Steeriing Committee. Clin Exp Allergy 1998; 28: Suppl 5, 52-66. Discussion 90-91.
37. Artlich A, Busch T, Lewandowski K, Schaible T, Falke KJ, Gortner L. Exhaled nitric oxide in preterm infants. Respir Physiol 1998; 114: 195-200.
38. Giraud GD, Nejadnik B, Kimberly B, Holden WE. Physical characteristics and gas composition of nasal air affect nasal nitric oxide release. Respir Physiol 1998; 114: 285-296.
39. Imada M, Iwamoto J, Nonaka S, Kobayashi Y, Unno T. Measurement of nitric oxide in human nasal airway. Eur Respir J 1996; 9: 556-559.
40. Qian W, Djupesland PG, Chatkin JM, et al. Aspiration flow optimized for nasal nitric oxide measurement. Rhinology 1999; 37: 61-65.
41. Bartley J, Fergusson W, Moody A, Wells AU, Kolbe J. Normal adult values, diurnal variation, and repeatability of nasal nitric oxide measurement. Am J Rhinol 1999; 13: 401-405.
42. Kharitonov SA, Logan-Sinclair RB, Busset CM, Shinebourne EA. Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J 1994; 72: 243-245.
43. Silkoff PE, Chatkin J, Qian W, et al. Nasal nitric oxide: a comparison of measurement techniques. Am J Rhinol 1999; 13: 169-178.
44. Arnal JF, Tack I, Besombes JP, Pipy B, Negre-Salvayre A. Nitric oxide and superoxide anion production during endothelial cell proliferation. Am J Physiol 1996; 271: C1521-526.
45. Recommendations for standardized procedures for the online and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999; 160: 2104-2117.
46. Qian W, Chatkin JM, Djupesland PG, et al. Unilateral nasal nitric oxide measurement after nasal surgery. Ann Otol Rhinol Laryngol 2000; 109: 952-957.
47. Kirihene RK, Rees G, Wormald PJ. The influence of the size of the maxillary sinus ostium on the nasal and sinus nitric oxide levels. Am J Rhinol 2002; 16: 261-264.
48. Weiglein A, Anderhuber W, Wolf G. Radiologic anatomy of the paranasal sinuses in the child. Surg Radiol Anat 1992; 14: 335-339.
49. Jones N. The nose and paranasal sinuses physiology and anatomy. Adv Drug Deliv Rev 2001; 51: 5-19.
50. Jaw TS, Sheu RS, Liu GC, Lin WC. Development of adenoids: a study by measurement with MR images. Kaohsiung J Med Sci 1999; 15: 12-18.